Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

Fraser, G (author)

Cramer, P (author)

Demirkan, F (author)

show more...

Silva, RS (author)

Grosicki, S (author)

Pristupa, A (author)

Janssens, A (author)

Mayer, J (author)

Bartlett, NL (author)

Dilhuydy, MS (author)

Pylypenko, H (author)

Loscertales, J (author)

Avigdor, A (author)

Rule, S (author)

Villa, D (author)

Samoilova, O (author)

Panagiotidis, P (author)

Goy, A (author)

Pavlovsky, MA (author)

Karlsson, C (author)

Karolinska Institutet

Hallek, M (author)

Mahler, M (author)

Salman, M (author)

Sun, S (author)

Phelps, C (author)

Balasubramanian, S (author)

Howes, A (author)

Chanan-Khan, A (author)

show less...

 (creator_code:org_t)

2018-10-12

2019

English.

In: Leukemia. - : Springer Science and Business Media LLC. - 1476-5551 .- 0887-6924. ; 33:4, s. 969-980

Related links:

https://www.nature.c...

show more...

http://kipublication...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)